SG Americas Securities, LLC - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 196 filers reported holding MYRIAD GENETICS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$941
+204.5%
58,688
+339.7%
0.01%
+450.0%
Q2 2023$309
+2.7%
13,348
+3.1%
0.00%
-33.3%
Q1 2023$301
+6.4%
12,951
-33.5%
0.00%0.0%
Q4 2022$283
-100.0%
19,477
-35.0%
0.00%
-57.1%
Q3 2022$572,000
-40.6%
29,966
-43.4%
0.01%
-30.0%
Q2 2022$963,000
-1.8%
52,989
+36.1%
0.01%
+42.9%
Q1 2022$981,000
-49.6%
38,939
-44.8%
0.01%
-36.4%
Q4 2021$1,947,000
+12.8%
70,550
+32.0%
0.01%
+37.5%
Q3 2021$1,726,000
+933.5%
53,445
+881.4%
0.01%
+700.0%
Q2 2021$167,000
-89.4%
5,446
-89.5%
0.00%
-87.5%
Q1 2021$1,576,000
+109.6%
51,743
+36.0%
0.01%
+100.0%
Q4 2020$752,000
+26.2%
38,052
-16.8%
0.00%0.0%
Q3 2020$596,000
+199.5%
45,713
+159.9%
0.00%
+100.0%
Q2 2020$199,000
-32.8%
17,588
-15.0%
0.00%
-33.3%
Q1 2020$296,000
-47.9%
20,683
-0.9%
0.00%
-40.0%
Q4 2019$568,000
+49.1%
20,861
+56.9%
0.01%
+66.7%
Q3 2019$381,000
-19.8%
13,292
-22.2%
0.00%0.0%
Q2 2019$475,000
-1.2%
17,085
+18.0%
0.00%
-25.0%
Q1 2019$481,000
-81.5%
14,478
-83.8%
0.00%
-82.6%
Q4 2018$2,598,000
+615.7%
89,370
+821.0%
0.02%
+666.7%
Q2 2018$363,000
-30.9%
9,704
-45.4%
0.00%
-25.0%
Q1 2018$525,000
+129.3%
17,779
+166.4%
0.00%
+100.0%
Q4 2017$229,000
+34.7%
6,673
+42.2%
0.00%
+100.0%
Q3 2017$170,000
+68.3%
4,694
+19.8%
0.00%0.0%
Q2 2017$101,000
-66.3%
3,917
-78.2%
0.00%
-66.7%
Q4 2016$300,000
-26.5%
17,968
-9.4%
0.00%
-25.0%
Q3 2016$408,000
+240.0%
19,835
+407.5%
0.00%
+300.0%
Q2 2016$120,000
-59.0%
3,908
-50.0%
0.00%
-50.0%
Q1 2016$293,000
+71.3%
7,822
+97.2%
0.00%
+100.0%
Q4 2015$171,000
-35.5%
3,967
-44.0%
0.00%
-50.0%
Q3 2015$265,000
-15.1%
7,080
-22.8%
0.00%0.0%
Q2 2015$312,000
+110.8%
9,168
+119.5%
0.00%
+100.0%
Q1 2015$148,000
-72.4%
4,176
-73.5%
0.00%
-66.7%
Q4 2014$537,000
-28.1%
15,761
-18.6%
0.00%
-25.0%
Q3 2014$747,000
+445.3%
19,366
+451.4%
0.00%
+300.0%
Q2 2014$137,000
+3.0%
3,512
-10.0%
0.00%0.0%
Q1 2014$133,000
-85.4%
3,901
-91.0%
0.00%
-75.0%
Q4 2013$911,000
+167.2%
43,437
+199.2%
0.00%
+300.0%
Q3 2013$341,00014,5170.00%
Other shareholders
MYRIAD GENETICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$98,875,0003.47%
Tieton Capital Management, LLC 187,636$3,711,0002.72%
Glenview Capital Management 3,682,691$72,825,0001.67%
Altium Capital Management LP 218,650$4,324,0001.61%
S&T BANK/PA 331,098$6,547,0001.18%
EARNEST PARTNERS LLC 6,731,429$133,114,0000.92%
DISCIPLINED GROWTH INVESTORS INC /MN 2,078,075$41,094,0000.79%
SummerHaven Investment Management, LLC 35,700$706,0000.55%
AIMZ Investment Advisors, LLC 42,685$844,0000.44%
CONTINENTAL ADVISORS LLC 36,392$720,0000.33%
View complete list of MYRIAD GENETICS INC shareholders